3rd Annual Gene Therapy for Neurological Disorders Europe
Evvnt Promotion / evvnt
Archivio
11.07.2022 - 13.07.2022 Pullman Paris La Défense, 11 Avenue de l'Arche, 92400 Courbevoie, Île-de-France, France
Time: 11:00 AM - 6:30 PM
Temi della conferenza
Navigating Europe-Specific Challenges & European Regulators Requirements; Optimizing Preclinical Research in Neurological Models & Revolutionizing Gene Therapy Delivery to CNS Targets in the Clinic
With systemic toxicity challenges plaguing the AAV field, low-dose CNS indications are an ideal target for gene therapy.
Navigating Europe-Specific Challenges & European Regulators Requirements; Optimizing Preclinical Research in Neurological Models & Revolutionizing Gene Therapy Delivery to CNS Targets in the Clinic
With systemic toxicity challenges plaguing the AAV field, low-dose CNS indications are an ideal target for gene therapy.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Informazioni ed Iscrizioni:
https://go.evvnt.com/1075884-3?pid=4832
Ms. Emily Lincoln
Medicina General
Lingua
Inglese
Inglese
Quote del Congresso
Drug Developer Pricing - Physical - Full Access Pass (Conference + Workshop Day) USD 3996.00 Drug Developer Pricing - Physical - Conference Only USD 2799.00
Drug Developer Pricing - Physical - Full Access Pass (Conference + Workshop Day) USD 3996.00 Drug Developer Pricing - Physical - Conference Only USD 2799.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
